Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ironwood Pharmaceuticals, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
IRWD
Nasdaq
8731
https://www.ironwoodpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ironwood Pharmaceuticals, Inc.
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
- May 12th, 2024 12:40 pm
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
- May 10th, 2024 5:58 pm
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
- May 10th, 2024 4:59 pm
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
- May 10th, 2024 3:16 pm
Ironwood Pharmaceuticals First Quarter 2024 Earnings: US$0.03 loss per share (vs US$0.30 profit in 1Q 2023)
- May 10th, 2024 1:30 pm
Ironwood Pharmaceuticals Reports First Quarter 2024 Results
- May 9th, 2024 11:00 am
Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
- May 6th, 2024 8:01 pm
Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
- May 2nd, 2024 5:34 pm
Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
- May 2nd, 2024 2:01 pm
Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
- May 1st, 2024 11:30 am
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
- Apr 30th, 2024 5:16 pm
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
- Apr 25th, 2024 8:01 pm
OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
- Mar 25th, 2024 1:57 pm
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
- Mar 5th, 2024 6:05 pm
Ironwood Pharmaceuticals Ran Up 38% Over Three Months — And Just Lost It All
- Feb 29th, 2024 9:19 pm
Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
- Feb 29th, 2024 11:00 am
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
- Feb 23rd, 2024 12:30 pm
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
- Feb 17th, 2024 12:50 pm
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 3:15 pm
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
- Feb 16th, 2024 2:36 pm
Scroll